A groundbreaking study has revealed that fotagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, significantly enhances ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not ...

The addition of fotagliptin to metformin treatment shows enhanced and clinically meaningful glycemic control in patients with ...

Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

When it comes to weight loss, there are a number of tried and true lifestyle changes you can make to help you along the way.

The common diabetes drug metformin can protect against dementia and Alzheimer’s in overweight and obese adults, according to new research published in the journal Diabetes, Obesity and Metabolism. The ...

Using metformin, a traditionally prescribed diabetes drug, is linked to an 8%-12% lower risk for dementia in patients with ...

New research in Diabetes, Obesity and Metabolism reveals that metformin, a medication traditionally prescribed to treat ...

Low, clinically relevant doses of metformin lower blood glucose by inhibiting the Rap1 protein in specific neurons of the ...

A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

People taking GLP-1 agonists for diabetes have a significantly lower risk of developing dementia compared to those using ...

6·3% of those who had taken metformin while infected with the SARS-CoV-2 ended up getting diagnosed with long Covid versus 10.4% of those who had received placebo only.